ICD-10-CM Billable Code

C85.13

Unspecified B-cell lymphoma, intra-abdominal lymph nodes

Clinical Classification Guidelines

Medical Intelligence & Overview

Unspecified B-cell lymphoma located in intra-abdominal lymph nodes is a form of non-Hodgkin lymphoma that affects B-lymphocytes, a type of white blood cell involved in the immune response. This condition develops within lymph nodes situated in the abdominal area, including regions like the mesenteric, retroperitoneal, and other intra-abdominal lymph nodal groups. The classification 'unspecified' indicates that the specific subtype of B-cell lymphoma has not been determined. Proper diagnosis and understanding of this condition are essential for effective management and treatment planning.

Causes & Symptoms

Clinical Causes: Genetic mutations affecting B-cell development Exposure to certain chemicals or radiation Immune system deficiencies or suppression Infections caused by viruses such as Epstein-Barr virus (EBV) or hepatitis C Chronic immune stimulation or inflammation

Key Symptoms: Abdominal swelling or pain Unexplained weight loss Fatigue or weakness Loss of appetite B symptoms such as fever and night sweats Palpable lumps in the abdomen Digestive disturbances such as nausea or vomiting Swelling of lymph nodes in the abdomen

Diagnostic & Treatment

Diagnosis Path: Diagnosing unspecified B-cell lymphoma in intra-abdominal lymph nodes involves multiple steps, including physical examinations, imaging techniques, and laboratory tests. Common methods include: - **Physical Examination:** Checking for enlarged lymph nodes and abdominal masses. - **Imaging Studies:** CT scans, PET scans, or MRI to identify the location and extent of lymph node involvement. - **Biopsy:** Obtaining tissue samples via needle biopsy or surgical excision for microscopic examination. - **Laboratory Tests:** Blood tests to evaluate overall health and detect abnormal cells, along with immunophenotyping to identify specific B-cell markers. - **Bone Marrow Examination:** To assess potential spread to the bone marrow. Based on these assessments, medical professionals can establish the diagnosis and determine the specific characteristics of the lymphoma, although in this case, the exact subtype remains unspecified.

Treatment Protocols: Treatment approaches for unspecified B-cell lymphoma in intra-abdominal lymph nodes typically depend on the disease stage, patient health status, and specific characteristics of the lymphoma. Common treatment options include: - **Chemotherapy:** The primary approach, often utilizing regimens such as R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone). - **Immunotherapy:** Using targeted therapies like monoclonal antibodies to enhance the immune response against cancer cells. - **Radiation Therapy:** May be considered for localized disease or residual lymph node involvement. - **Stem Cell Transplantation:** For advanced or relapsed cases, enabling higher-dose chemotherapy. - **Supportive Care:** Managing symptoms and maintaining overall health during treatment. Since the lymphoma is unspecified, treatment plans are tailored to individual patient profiles after a comprehensive medical evaluation.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is C85.13 a billable ICD-10 code?
Yes, C85.13 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report C85.13?
Clinical documentation must specify the nature of Unspecified B-cell lymphoma, intra-abdominal lymph nodes and any associated comorbidities for accurate reporting.

Cite this Clinical Reference